Board of Directors

Lars Martin

Chairman of the Board

Lars is a senior manager in pharmaceutical industry for more than 30 years with sales and marketing positions at GlaxoSmithKline, MSD and Clinical Data Care. He has also been venture capital investment manager.

Carl-Johan Spak, PhD

Board member

Carl-Johan is Senior Vice President Strategic Investments and Projects at Recipharm. He has 35 years experience in pharmaceutical industry with positions as managing director and CEO in small startup companies as well as larger pharmaceutical companies. Carl-Johan has a PhD in dentistry and pharmacology.

Prof. Hans Lennernäs

Board member

Hans is co-founder and part of the operational Empros team

Ulf Holmbäck, PhD

Board member

Ulf is co-founder of Empros Pharma and part of the operational Empros team

Assoc. Prof. Anders Forslund, MD

Substitute Board member

Anders is co-founder of Empros Pharma and part of the operational Empros team

Thomas Eldered

Substitute Board member

Thomas is one of Empros Pharmas investors. Thomas is CEO and co-founder of Recipharm. He is a recognized serial entrepreneur and business developer. Through his investment firms, he is investing in start-ups as well as established companies, mainly in the life science sector.

Other Partners

In addition to our Board members and investors, we work in close collaboration with a growing number of industrial and professional partners.

Recipharm –

CDMO specialists taking products from early development through to commercial manufacturing


Chas. Hude –

Intellectual property experts based in Copenhahen


Clinical Trial Consultants –

Hospital-based early phase clinical trials (phase 0/I-IIa) in patients and healthy volunteers